Young Hak Kim Selected Research

Communicable Diseases (Infectious Diseases)

1/2019

Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Young Hak Kim Research Topics

Disease

88	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 11/2004
36	Neoplasms (Cancer) 06/2023 - 11/2008
18	Lung Neoplasms (Lung Cancer) 06/2023 - 05/2006
14	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 11/2008
13	Neoplasm Metastasis (Metastasis) 01/2017 - 09/2005
8	Adenocarcinoma of Lung 04/2023 - 11/2004
6	Brain Neoplasms (Brain Tumor) 08/2023 - 04/2010
6	Disease Progression 01/2023 - 09/2011
4	Pleural Effusion (Pleural Effusions) 06/2023 - 09/2010
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018 - 08/2012
3	Infections 01/2021 - 08/2011
3	Adenocarcinoma 01/2017 - 11/2004
3	Coronary Artery Disease (Coronary Atherosclerosis) 06/2014 - 11/2008
2	Malignant Mesothelioma 11/2019 - 07/2012
2	Pneumonia (Pneumonitis) 01/2018 - 07/2012
2	Carcinogenesis 09/2017 - 11/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2017 - 02/2013
2	Thymoma (Thymic Carcinoma) 05/2016 - 05/2006
2	Pain (Aches) 12/2013 - 03/2013
2	Diarrhea 07/2013 - 10/2011
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2011 - 05/2010
2	Breast Neoplasms (Breast Cancer) 07/2009 - 04/2009
1	Cachexia 04/2023
1	Radiation Pneumonitis 01/2021
1	Nontuberculous Mycobacterium Infections 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Eosinophilia 11/2019
1	Communicable Diseases (Infectious Diseases) 01/2019

Drug/Important Bio-Agent (IBA)

26	ErbB Receptors (EGF Receptor)IBA 08/2023 - 10/2008
16	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2023 - 04/2010
15	Tyrosine Kinase InhibitorsIBA 08/2023 - 10/2008
13	NivolumabIBA 12/2022 - 01/2017
12	Gefitinib (Iressa)FDA Link 07/2018 - 11/2004
11	Anaplastic Lymphoma KinaseIBA 01/2023 - 01/2013
9	PlatinumIBA 04/2023 - 04/2009
9	Pemetrexed (MTA)FDA Link 05/2020 - 03/2011
9	alectinibIBA 01/2020 - 02/2015
8	CrizotinibIBA 01/2020 - 01/2013
6	Bevacizumab (Avastin)FDA Link 05/2020 - 07/2010
5	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2018
4	Epidermal Growth Factor (EGF)IBA 06/2023 - 04/2010
4	Carboplatin (JM8)FDA LinkGeneric 05/2020 - 09/2009
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2011
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2009
4	SolventsIBA 10/2017 - 12/2013
4	Gemcitabine FDA Link 12/2013 - 09/2009
3	RamucirumabIBA 08/2023 - 01/2023
3	osimertinibIBA 06/2023 - 06/2018
3	AlbuminsIBA 04/2023 - 07/2016
3	B7-H1 AntigenIBA 04/2023 - 06/2022
3	LigandsIBA 04/2023 - 01/2020
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2020 - 04/2009
3	Albumin-Bound Paclitaxel FDA Link 10/2017 - 05/2016
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2017 - 01/2015
3	Phosphotransferases (Kinase)IBA 02/2015 - 04/2010
3	OSI-420IBA 09/2011 - 05/2010
2	Docetaxel (Taxotere)FDA Link 10/2023 - 06/2013
2	C-Reactive ProteinIBA 04/2023 - 01/2010
2	Etoposide (VP 16)FDA LinkGeneric 04/2023 - 01/2023
2	amrubicinIBA 03/2020 - 05/2010
2	ParaffinIBA 05/2019 - 02/2013
2	Formaldehyde (Formol)FDA Link 05/2019 - 02/2013
2	AfatinibIBA 01/2019 - 01/2017
2	ceritinibIBA 11/2018 - 09/2018
2	130-nm albumin-bound paclitaxelIBA 10/2017 - 07/2016
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2017 - 09/2012
2	Cisplatin (Platino)FDA LinkGeneric 11/2015 - 04/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2013 - 08/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2013 - 04/2011
2	Insulin-Like Growth Factor Binding Protein 3IBA 09/2012 - 10/2011
2	Insulin-Like PeptidesIBA 09/2012 - 10/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2012 - 11/2010
2	BRCA1 ProteinIBA 07/2009 - 04/2009
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2023
1	Growth Differentiation Factor 15IBA 04/2023
1	lorlatinibIBA 01/2023
1	BezafibrateIBA 12/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 06/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	durvalumabIBA 01/2021
1	navitoclaxIBA 01/2020
1	Apoptosis Regulatory ProteinsIBA 01/2020
1	S63845IBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	saracatinibIBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	src-Family KinasesIBA 01/2019

Therapy/Procedure

31	Drug Therapy (Chemotherapy) 04/2023 - 05/2006
18	Therapeutics 06/2023 - 01/2010
4	Combination Drug Therapy (Combination Chemotherapy) 10/2023 - 07/2009
4	Chemoradiotherapy 01/2021 - 03/2016
3	Immunotherapy 12/2022 - 01/2019
3	Radiotherapy 01/2022 - 05/2006
3	Drug-Eluting Stents 06/2014 - 11/2008
3	Percutaneous Coronary Intervention 06/2014 - 02/2012
2	Cranial Irradiation 08/2021 - 12/2016
2	Aftercare (After-Treatment) 01/2020 - 09/2017
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2014 - 11/2013
2	Maintenance Chemotherapy 01/2013 - 11/2011
2	Renal Dialysis (Hemodialysis) 04/2011 - 05/2010